Evaluation of Nutritional Status in Thalassemia Major Patients in Assiut Children Hospital

Sponsor
Assiut University (Other)
Overall Status
Completed
CT.gov ID
NCT03161899
Collaborator
(none)
246
1
19.2
12.8

Study Details

Study Description

Brief Summary

Thalassemia is a blood disorder passed down through families in which the body makes an abnormal form of hemoglobin. There are 2 main types of thalassemia; Alpha & Beta thalassemia. Alpha thalassemia: occurs when a gene or genes related to the alpha globin protein are missing or mutated.

Beta-thalassemia syndromes are a group of hereditary blood disorders characterized by reduced or absent beta globin chain synthesis. Beta-thalassemias can be classified into:

Silent carrier: completely asymptomatic with normal hematological parameters. Beta-thalassaemia minor (beta-thalassaemia trait): usually asymptomatic; diagnosis is made during a work-up for mild anemia.

Beta-thalassaemia intermedia: usually a similar presentation to beta-thalassaemia major; symptoms are usually less pronounced and the course is usually more insidious.

Beta-thalassaemia major : In which there is complete absence of hemoglobin A

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    In Egypt beta thalassemia-major is the most common type with carrier rate of 5.3 to ≥9%and 1000 new cases born with beta-thalassemia major per 1.5 million live births per year.

    Children born with thalassemia major are normal at birth, but develop severe hemolytic anemia during the first year of life. Symptoms are those of anemia (lethargy, poor feeding, pallor…etc.) failure to thrive and organomegaly. Later on they develop signs of extra medullary hematopoiesis .

    Optimal nutritional status is important for growth, immune function, bone health and pubertal development . Various reports suggest the incidence of poor growth ranges from 25% to 75% depending on thalassemia syndrome and severity of disease. This marked growth deficits raise a red flag for any pediatrician to evaluate nutritional status of thalassemic patients and detect possible nutritional deficiencies and associated factors.

    Etiology of delayed growth and malnutrition reported in thalassemic patient is multifactorial including :

    1. Nutritional deprivation with or without feeding difficulties arising from fatigue and breathlessness

    2. Increased energy expenditure secondary to hyper metabolism with or without heart failure

    3. Gastrointestinal hypoxia which consequently produces anorexia and malabsorption

    4. Reduction of biosynthetic activity of liver.

    5. Disturbance of the endocrine function

    6. Impaired synthetic hepatic function secondary to hemosiderosis and hepatitis.

    The main aim of this study is to assess the nutritional status of thalassemic patient attending Assiut university Children hospital and to determine the factors involved.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    246 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Cross-Sectional
    Official Title:
    Evaluation of Nutritional Status in Patients With Thalassemia Major in Assiut University Children Hospital
    Actual Study Start Date :
    Dec 15, 2018
    Actual Primary Completion Date :
    May 24, 2020
    Actual Study Completion Date :
    Jul 20, 2020

    Outcome Measures

    Primary Outcome Measures

    1. percentage of malnutrition [12 month]

      prevalence of malnutrition among thalassemic children attending assiut university children hospital

    Secondary Outcome Measures

    1. aetiology poor growth [12 month]

      determination of the most common causes responsible for poor growth seen in thalassemic patients

    2. decrease morbidity [18 month]

      decrease morbidity by providing possible strategies for early prevention of the problem of poor growth occurring in patients with thalassemia major

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    6 Years to 14 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patients diagnosed to have thalassemia
    Exclusion Criteria:
    • patient with any underlaying systemic diseases other than B thalassemia major.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Asmaa Refaat Abdelmonem Assiut Egypt

    Sponsors and Collaborators

    • Assiut University

    Investigators

    • Principal Investigator: asmaa refaat, MBBCH, Assuit , faculty of medicine, egypt

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    ARAbdelmonem, resident doctor of pediatrics, Assiut University
    ClinicalTrials.gov Identifier:
    NCT03161899
    Other Study ID Numbers:
    • ENST
    First Posted:
    May 22, 2017
    Last Update Posted:
    Jul 30, 2020
    Last Verified:
    Jul 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by ARAbdelmonem, resident doctor of pediatrics, Assiut University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 30, 2020